Ensuring Relevance and Equity in Patient Reported Outcomes (pros) in Gynecologic Malignancy: the PROMOTE Study (Patient-Reported Outcomes Measurement Opportunities Through Equity) (1324)

To date, the Functional Assessment of Cancer Therapy – Endometrial – Total Outcome Index (FACT-En-TOI) has been the most widely used patient-reported outcomes (PRO) measure in US endometrial cancer clinical trials. This measure has been shown to be responsive to changes in physical and functional outcomes associated with endometrial cancer disease and treatment. However, many essential PRO measures, including the FACT-Endometrial, have not been re-examined to reflect the perspectives and experiences of an increasingly diverse group of patients.